Your browser doesn't support javascript.
loading
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.
Miller, Ian; Scheffer, Ingrid E; Gunning, Boudewijn; Sanchez-Carpintero, Rocio; Gil-Nagel, Antonio; Perry, M Scott; Saneto, Russell P; Checketts, Daniel; Dunayevich, Eduardo; Knappertz, Volker.
Afiliação
  • Miller I; Department of Neurology, Nicklaus Children's Hospital, Miami, Florida.
  • Scheffer IE; Epilepsy Research Centre, The University of Melbourne at Austin Health and the Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Gunning B; Florey Institute, Melbourne, Victoria, Australia.
  • Sanchez-Carpintero R; Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Gil-Nagel A; Stichting Epilepsie Instellingen Nederland, Zwolle, the Netherlands.
  • Perry MS; Pediatric Neurology Unit, Clínica Universidad de Navarra, Navarra Institute for Health Research, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.
  • Saneto RP; Department of Neurology, Hospital Ruber Internacional, Madrid, Spain.
  • Checketts D; Jane and John Justin Neurosciences Center, Cook Children's Medical Center, Ft Worth, Texas.
  • Dunayevich E; Neuroscience Institute, Division of Pediatric Neurology, Department of Neurology, Seattle Children's Hospital and University of Washington, Seattle.
  • Knappertz V; GW Research, Ltd, Cambridge, United Kingdom.
JAMA Neurol ; 77(5): 613-621, 2020 05 01.
Article em En | MEDLINE | ID: mdl-32119035

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Convulsões / Canabidiol / Epilepsias Mioclônicas / Anticonvulsivantes Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Convulsões / Canabidiol / Epilepsias Mioclônicas / Anticonvulsivantes Idioma: En Ano de publicação: 2020 Tipo de documento: Article